Structural and mechanistic profiling of Nurr1 modulation by vidofludimus enables structure-guided ligand design
Abstract The neuroprotective transcription factor nuclear receptor related 1 (Nurr1, NR4A2) is in the focus of biomedical research for its promising neuroprotective role in Parkinson’s disease, Alzheimer’s disease, and multiple sclerosis. Its activity can be controlled by ligands offering access to...
Saved in:
| Main Authors: | Úrsula López-García, Jan Vietor, Julian A. Marschner, Jan Heering, Vasily Morozov, Thomas Wein, Daniel Merk |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Communications Chemistry |
| Online Access: | https://doi.org/10.1038/s42004-025-01553-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular basis of ligand-dependent Nurr1-RXRα activation
by: Xiaoyu Yu, et al.
Published: (2023-04-01) -
Correction: Molecular basis of ligand-dependent Nurr1-RXRα activation
by: Xiaoyu Yu, et al.
Published: (2025-04-01) -
NURR1 Downregulation Favors Osteoblastic Differentiation of MSCs
by: Adriana Di Benedetto, et al.
Published: (2017-01-01) -
Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease
by: Sang‐Min Oh, et al.
Published: (2015-03-01) -
Nurr1 deficiency impairs autophagy-lysosomal function through GBA-dependent transcriptional regulation in Parkinson’s disease pathogenesis
by: Cheng Cheng, et al.
Published: (2025-06-01)